Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats

An ideal animal model is necessary for a clear understanding of the etiology, pathogenesis, and mechanisms of human non-alcoholic steatohepatitis (NASH) and for facilitating the design of effective therapy for this condition. We aimed to establish a rat model of NASH with fibrosis by using a high-fat diet (HFD). Male Sprague–Dawley (SD) rats were fed a HFD consisting of 88 g normal diet, 10 g lard oil, and 2 g cholesterol. Control rats were fed normal diet. Rats were killed at 4, 8, 12, 16, 24, 36, and 48 weeks after HFD exposure. Body weight, liver weight, and epididymal fat weight were measured. Serum levels of fasting glucose, triglyceride, cholesterol, alanine aminotransferase (ALT), free fatty acids (FFA), insulin, and tumor necrosis factor-alpha (TNF-α) were determined. Hepatic histology was examined by H&E stain. Hepatic fibrosis was assessed by VG stain and immunohistochemical staining for transforming growth factor beta 1 (TGF-β1), and alpha-smooth-muscle actin (α-SMA). The liver weight and liver index increased from week 4, when hepatic steatosis was also observed. By week 8, the body weight and epididymal fat weight started increasing, which was associated with increased serum levels of FFA, cholesterol, and TNF-α, as well as development of simple fatty liver. The serum ALT level increased from week 12. Steatohepatitis occurred from weeks 12 through 48. Apparent hepatic perisinosodial fibrosis did not occur until week 24, and progressed from week 36 to 48 with insulin resistance. Therefore, this novel model may be potentially useful in NASH study.

• Publication year

  2009

• Venue

  Digestive Diseases and Sciences

• Publication date

  2009-05-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10620-009-0815-3PMID 19459046PMCID 2946554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of non-alcoholic fatty liver disease in China.

  2009cited by this paper
• Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet.

  2008cited by this paper
• Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis

  2008cited by this paper
• VAT fat is bad for the liver, SAT fat is not!

  2008cited by this paper
• A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.

  2008cited by this paper
• Effects of nonalcoholic fatty liver disease on the development of metabolic disorders

  2007cited by this paper
• GI Epidemiology: nonalcoholic fatty liver disease

  2007cited by this paper
• What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?

  2007cited by this paper
• Pathogenesis of NASH: animal models.

  2007influential reference
• Not all models of fatty liver are created equal: Understanding mechanisms of steatosis development is important

  2007cited by this paper
• Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver.

  2007cited by this paper
• Lipid‐induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet

  2007cited by this paper
• Long term highly saturated fat diet does not induce NASH in Wistar rats

  2007cited by this paper
• Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo

  2007cited by this paper
• Epidemiology and natural history of NAFLD and NASH.

  2007cited by this paper
• Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis.

  2007cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006influential reference
• A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.

  2006cited by this paper
• High-fat emulsion-induced rat model of nonalcoholic steatohepatitis.

  2006cited by this paper
• Leptin‐mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats

  2006cited by this paper
• Global challenges in liver disease

  2006cited by this paper
• Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model.

  2005cited by this paper
• Steatohepatitis develops rapidly in transgenic mice overexpressing Abcb11 and fed a methionine-choline-deficient diet.

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Steatohepatitis induced by intragastric overfeeding in mice

  2005cited by this paper
• Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin.

  2004cited by this paper
• Model of nonalcoholic steatohepatitis.

  2004cited by this paper
• Another animal model for nonalcoholic steatohepatitis: how close to the human condition?

  2004cited by this paper
• Animal models of nonalcoholic fatty liver disease and steatohepatitis.

  2004cited by this paper
• Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis.

  2004cited by this paper
• The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

  2004cited by this paper
• Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

  2003cited by this paper
• Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver

  2002cited by this paper
• Obesity‐related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2

  2002cited by this paper
• Leptin is essential for the hepatic fibrogenic response to chronic liver injury.

  2002cited by this paper

• A Global Perspective on Metabolic Dysfunction-Associated Steatotic Liver Disease: From Molecular Mechanisms to Therapeutic Strategy Innovation.

  2026cites this paper
• Unveiling MASH: A Comprehensive Review Highlighting Experimental Insights, Molecular Pathogenesis, and Therapeutic Approaches.

  2026cites this paper
• Dual calcium-ACE inhibition reverses non alcoholic fatty pancreas progression: Mechanistic convergence on miR-762/GPX4 driven NLRP3 inflammasome activation.

  2026cites this paper
• Pathophysiological Role of Neutrophil Extracellular Traps in Diet-Induced Obesity and Metabolic Syndrome in Animal Models

  2025cites this paper
• A Guide to Pathophysiology, Signaling Pathways, and Preclinical Models of Liver Fibrosis.

  2025cites this paper
• Applications of Danio rerio as a model for studying NAFLD and NASH

  2025cites this paper
• Tangeretin Unravels Metabolic Dysfunction-Associated Fatty Liver Disease in Rats by Enhancing the IRS/Akt Pathway

  2025cites this paper
• Study of the combined protective effect of adrenomedullin and exercise on induced fatty liver in male albino rats: A possible role of peroxisome proliferator-activated receptor-alpha

  2025influential citation
• Effect of Spirulina platensis Versus Simvastatin on the Skeletal Muscles of Experimentally Induced Dyslipidemia: A Multitarget Approach to Muscle Ultrastructural and Cytomolecular Modulation

  2025cites this paper
• Integrated profiling of adiponectin and cytokine signaling pathways in high-fat diet-induced MASLD reveals early markers of disease progression

  2025cites this paper
• Amaranthus graecizans L. Mitigates Hyperlipidemia-Induced Nonalcoholic Fatty Liver Disease in Experimental Rats: Future Pharmaceuticals

  2025cites this paper
• Carvacrol-Loaded Chitosan Nanoparticles as a Multifunctional Nanotherapeutic Strategy Targeting Oxidative Stress, Inflammation, Apoptosis, and Genotoxicity in Nonalcoholic Fatty Liver Disease

  2025cites this paper
• Potentiation and in vivo evaluation of anti-obesity activity of berberine through encapsulation in guar-acacia gum nanocomplexes

  2024cites this paper
• Pathophysiological Features of Rat Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

  2024cites this paper
• The differential effects of palmitic acid and oleic acid on the metabolic response of hypothalamic astrocytes from male and female mice

  2024cites this paper
• A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation

  2024cites this paper
• EFFECT OF DIETARY INTERVENTION WITH SEEDS AND SPROUTS OF BROCCOLI ON THE NONALCOHOLIC FATTY LIVER IN THE ALBINO RAT MODEL

  2024cites this paper
• Rodent model of metabolic dysfunction‐associated fatty liver disease: a systematic review

  2024cites this paper
• Effects of licorice root (Glycyrrhiza glabra) extract on the livers of obese rats*

  2024cites this paper
• Bilirubin, once a toxin but now an antioxidant alleviating non-alcoholic fatty liver disease in an autophagy-dependent manner in high-fat diet-induced rats: a molecular and histopathological analysis

  2024cites this paper
• Genistein relieves liver damage and improves lipid dysregulation through endoplasmic reticulum suppression in nonalcoholic steatohepatitis rats

  2024cites this paper
• Bilirubin, a hepatoprotective agent that activates SIRT1, PGC-1α, and PPAR-α, while inhibiting NF-κB in rats with metabolic-associated fatty liver disease

  2024cites this paper
• Crosstalk between Adipose Tissue and Hepatic Mitochondria in the Development of the Inflammation and Liver Injury during Ageing in High-Fat Diet Fed Rats

  2023cites this paper
• Short-Term Growth Hormone Administration Mediates Hepatic Fatty Acid Uptake and De Novo Lipogenesis Gene Expression in Obese Rats

  2023cites this paper
• Inhibitory effect of stinging nettle (Urtica dioica L.) extract on body weight gain in rats on a high-fat diet

  2023influential citation
• Effects of oleic acid and/or exercise on diet-induced thermogenesis and obesity in rats: involvement of beige adipocyte differentiation and macrophage M1 inhibition

  2023cites this paper
• Prebiotics Together with Raspberry Polyphenolic Extract Mitigate the Development of Nonalcoholic Fatty Liver Diseases in Zucker Rats

  2023cites this paper
• Strontium Attenuates Hippocampal Damage via Suppressing Neuroinflammation in High-Fat Diet-Induced NAFLD Mice

  2023cites this paper
• CS27109, A Selective Thyroid Hormone Receptor-β Agonist Alleviates Metabolic-Associated Fatty Liver Disease in Murine Models

  2023cites this paper
• Limited role for hyperammonemia in the progression of diet‐induced nonalcoholic steatohepatitis

  2023cites this paper
• Protective Mechanism of Nostoc sphaeroides Kütz. Polysaccharide on Liver Fibrosis by HFD-Induced Liver Fat Synthesis and Oxidative Stress

  2022cites this paper
• Black raspberry extract can lower serum LDL cholesterol via modulation of gut microbial composition and serum bile acid profile in rats fed trimethylamine-N-oxide with a high-fat diet

  2022cites this paper
• The gut–microbiota–brain changes across the liver disease spectrum

  2022influential citation
• Comparative study on the weight loss and lipid metabolism by tea polyphenols in diet induced obese C57BL/6J pseudo germ free and conventionalized mice

  2022cites this paper
• Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model

  2022cites this paper
• Hepatic‐Targeted Nano‐enzyme with Resveratrol Loading for Precise Relief of Nonalcoholic Steatohepatitis

  2022cites this paper
• Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm

  2022cites this paper
• Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms.

  2022cites this paper
• Saudi Traditional Fermented Goat Milk Protects against Experimental Non-Alcoholic Fatty Liver Disease by Hypoglycaemic and Antioxidant Potentials

  2022cites this paper
• Fructo-Oligosaccharides and Pectins Enhance Beneficial Effects of Raspberry Polyphenols in Rats with Nonalcoholic Fatty Liver

  2021cites this paper
• ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis

  2021cites this paper
• Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review

  2021cites this paper
• Investigation of Thiol/Disulfide Balance in Obese Rats with Non-Alcoholic Fatty Liver Disease

  2021influential citation
• Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH).

  2021cites this paper
• Effects of Myrtus communis L. Extract and Apocynin on Lens Oxidative Damage and Boron Levels in Rats with a High Fat-Diet

  2021cites this paper
• The Obscure Effect of Tribulus terrestris Saponins Plus Inulin on Liver Morphology, Liver Fatty Acids, Plasma Glucose, and Lipid Profile in SD Rats with and without Induced Type 2 Diabetes Mellitus

  2021cites this paper
• A comparative study on the effect of black cherry powder , ethanolic extract and atorvastatin on hyperlipidemic rats

  2021cites this paper
• Long noncoding RNAs associated with nonalcoholic fatty liver disease in a high cholesterol diet adult zebrafish model

  2021cites this paper
• Arq ajwain protects nonalcoholic fatty liver disease on high-fat diet-induced obese rat

  2021cites this paper
• Hepatic connective tissue growth factor expression and regulation differ between non-steatotic and non-alcoholic steatotic livers from brain-dead donor

  2021cites this paper
• Protective Effects of Black Raspberry (Rubus occidentalis) Extract against Hypercholesterolemia and Hepatic Inflammation in Rats Fed High-Fat and High-Choline Diets

  2020cites this paper
• Lipotoxic Hepatocyte‐Derived Exosomal MicroRNA 192‐5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease

  2020cites this paper
• Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?

  2020cites this paper
• Efficient drug and gene delivery to liver fibrosis: rationale, recent advances, and perspectives

  2020cites this paper
• The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

  2020influential citation
• Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats

  2020cites this paper
• Advances in animal models of diet-related nonalcoholic fatty liver disease

  2020cites this paper
• Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog /Gli and Wnt/ β-catenin signaling crosstalk.

  2020cites this paper
• Palm Weevil Larvae (Rhynchophorus phoenicis Fabricius) and Orange-Fleshed Sweet Potato-Enriched Biscuits Improved Nutritional Status in Female Wistar Albino Rats

  2020cites this paper
• Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: Targeting Nav1.7 channels and PPAR-γ.

  2020cites this paper
• Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?

  2020cites this paper
• Review on Non-alcoholic Fatty Liver Disease: Pathogenesis, Management and Treatment

  2020cites this paper
• Alternative Approaches to Ameliorate Nonalcoholic Fatty Liver Disease: Phyllanthus niruri Clinicopathological Significance; A review

  2020cites this paper
• EX-527 Prevents the Progression of High-Fat Diet-Induced Hepatic Steatosis and Fibrosis by Upregulating SIRT4 in Zucker Rats

  2020cites this paper
• Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development

  2020cites this paper
• Ability of prebiotic polysaccharides to activate a HIF1α-antimicrobial peptide axis determines liver injury risk in zebrafish

  2019cites this paper
• ω-imidazolyl-alkyl derivatives as new preclinical drug candidates for NASH therapy

  2019cites this paper
• Boosting via

  2019cites this paper
• New Insights on Nigella Sativa’s Protective Effect against High Fat Diet Induced Alteration ‎in Small Intestine and Liver of Rats: a Biochemical and Histological Study

  2019cites this paper
• Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits

  2019cites this paper
• Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine

  2019cites this paper
• Animal models of portal hypertension.

  2019cites this paper
• Mechanistic Studies of Cholesterol Lipotoxicity Pertinent to NASH

  2019cites this paper
• Effects of high fat medium conditions on cellular gene expression profile: a network analysis approach

  2019cites this paper
• A Comprehensive Study of High Cholesterol Diet-Induced Larval Zebrafish Model: A Short-Time In Vivo Screening Method for Non-Alcoholic Fatty Liver Disease Drugs

  2019cites this paper
• Diet-Induced Rat Model of Gradual Development of Non-Alcoholic Fatty Liver Disease (NAFLD) with Lipopolysaccharides (LPS) Secretion

  2019influential citation
• Lipotoxic Hepatocyte-Derived Exosomal miR-192-5p Activates Macrophages via Rictor/Akt/FoxO1 Signaling in NAFLD.

  2019cites this paper
• Is the Fatty Acids Profile in Blood a Good Predictor of Liver Changes? Correlation of Fatty Acids Profile with Fatty Acids Content in the Liver

  2019cites this paper
• Low-Level Saturated Fatty Acid Palmitate Benefits Liver Cells by Boosting Mitochondrial Metabolism via CDK1-SIRT3-CPT2 Cascade.

  2019cites this paper
• Aromatic aldehyde compound cuminaldehyde protects nonalcoholic fatty liver disease in rats feeding high fat diet

  2019cites this paper
• Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats

  2019cites this paper
• Biomathematical Model Study on the Association between Liver Fibrosis Disease and Anti-fibrotic Therapies Characteristics

  2018cites this paper
• Title Female spontaneously diabetic Torii fatty rats developnonalcoholic steatohepatitis-like hepatic lesions

  2018cites this paper
• Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis

  2018cites this paper
• Synergistic effect of carnosine on browning of adipose tissue in exercised obese rats; a focus on circulating irisin levels

  2018cites this paper
• Co-administration of conjugated linoleic acid and rosiglitazone increases atherogenic co-efficient and alters isoprenaline-induced vasodilatation in rats fed high fat diet.

  2018cites this paper
• Ferulic acid suppresses obesity and obesity-related metabolic syndromes in high fat diet-induced obese C57BL/6J mice

  2018cites this paper
• Relationship between Experimental Diet in Rats and Nonalcoholic Hepatic Disease: Review of Literature

  2018cites this paper
• CCl4 Induced Liver Fibrosis Model in Cynomolgus Monkeys

  2018cites this paper
• Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol

  2018cites this paper
• Mango phenolics increase the serum apolipoprotein A1/B ratio in rats fed high cholesterol and sodium cholate diets.

  2018cites this paper
• Biomathematical Analysis of the Liver Fibrosis

  2018cites this paper
• Switching from a high-fat cellulose diet to a high-fat pectin diet reverses certain obesity-related morbidities

  2018cites this paper
• Sulfated polysaccharide from Enteromorpha prolifera increases hydrogen sulfide production and attenuates non-alcoholic fatty liver disease in high-fat diet rats.

  2018cites this paper
• Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation

  2018cites this paper
• The Beneficial Effects of Silymarin in Treatment of Experimentally Induced Non-Alcoholic Fatty Liver Disease in Rats

  2018cites this paper
• Pulmonary , gastrointestinal and urogenital pharmacology Canagli fl ozin protects against non-alcoholic steatohepatitis in type-2 diabetic rats through zinc alpha-2 glycoprotein up-regulation

  2018cites this paper
• Yüksek Yağlı Diyet ile Beslenen Ratlarda Mate (Ilex paraguariensis) Çayının Obeziteyi Önleyici Etkisinin Histopatolojik ve Biyokimyasal Olarak Araştırılması

  2018cites this paper
• Morphometric Changes Due to β Carotene on Wistar Rats Fed Dietary Fat

  2018cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2018cites this paper